Signa Vitae. 2024; 20(6): 25-32. doi: 10.22514/sv.2024.068
Original Research

Characteristics and prognostic factors of HIV-positive adults in the emergency department of a university hospital in South Korea, 2013–2022

Seojun Lee1, Chae Hyeon Lee2, Young Ju Suh3, Yu Jin Lee1, Ji Hye Kim1, Seung Baik Han1, Areum Durey1,*,

1Department of Emergency Medicine, Inha University School of Medicine, 22332 Incheon, Republic of Korea

2The Biomedical Center, Biomedical Research Institute, Inha University Hospital, 22332 Incheon, Republic of Korea

3Department of Biomedical Sciences, Inha University School of Medicine, 22212 Incheon, Republic of Korea

*Corresponding Author(s):areum.durey@inha.ac.kr (Areum Durey)

History Submitted: 10 January 2024 | Accepted: 12 March 2024 | Published: 08 June 2024
Copyright:  ©2024  The Author(s). Published by MRE Press.
This is an open access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/).

Collapse table of contents

Abstract

An estimated 39 million individuals globally were living with human immunodeficiency virus (HIV) at the end of 2022 with approximately 1.3 million individuals newly infected during 2022. Similarly, the number of people living with HIV (PWH) has consistently increased in Korea and the number of PWH seeking emergency care is expected to increase. This study aimed to elucidate utilization patterns of emergency department (ED) of PWH and identify key indicators that predict admission and poor prognosis. This was a single-center retrospective study of HIV-positive adult patients who visited the ED between 01 January 2013 and 31 December 2022. Data was collected at the visit level and analyzed using the generalized estimating equation method. Visits were categorized into direct hospital admissions from the ED or discharges to home to evaluate admission-associated factors. Additionally, visits in the poor prognosis group were compared with the remainder to elucidate prognostic indicators. The poor prognosis group was defined as admitted visits with intensive care unit placement, visits with in-hospital mortality, or both. Annually, an average of 8.9 per 10,000 ED visits were made by PWH, with an admission rate of 49.8%. A total of 369 ED visits corresponding to 183 PWH were included in the analysis, and 93% of them were on highly active anti-retroviral therapy. Underlying chronic renal failure, presenting with fever or general weakness, supplemental oxygen administration, or ancillary department consultation in the ED increased admission odds. Ambulance use, high triage level and use of oxygen in the ED were associated with poor prognosis. Most notably, higher levels of blood urea nitrogen (BUN) or lactic acid were independent factors of poor prognosis. We hope these analytic insights from 10 years of institutional data will assist emergency physicians in providing timely informed care to HIV-infected individuals visiting the ED, ultimately leading to improved patient outcomes.

Keywords:Emergency department;HIV;Highly active antiretroviral therapy;Admission;Prognosis;South Korea
PDF(1.61 MB)|EndNote (RIS)|BibTeX|RefMan|RefWorks

Cite this article

Seojun Lee, Chae Hyeon Lee, Young Ju Suh, Yu Jin Lee, Ji Hye Kim, Seung Baik Han, Areum Durey. Characteristics and prognostic factors of HIV-positive adults in the emergency department of a university hospital in South Korea, 2013–2022. Signa Vitae. 2024; 20(6): 25-32. doi: 10.22514/sv.2024.068

1. Introduction

An estimated 39 million individuals globally were living with HIV at the end of 2022. Although the incidence of new HIV infections has declined since 2010, approximately 1.3 million individuals still acquired HIV in 2022 [1]. Similarly, in South Korea, the number of people infected with HIV has risen consistently since the detection of the first case of HIV infection in 1985. According to a report published by the Korea Centers for Disease Control and Prevention, 19,001 cumulative confirmed cases of HIV infection had been identified in South Korea as of 2022, with an average of 1100 new diagnoses annually since 2013 [2]. The number of South Koreans diagnosed with HIV increased by 9.3 % from 975 in 2021 to 1066 in 2022.

In parallel, the prognosis of people living with HIV (PWH) has substantially improved since 1997, following the introduction of combination antiretroviral therapy (ART). Continuous advances in pharmacological HIV treatments have facilitated recommendations for earlier initiation of ART [3]. As a result, the survival and estimated life expectancy of PWH on ART now approach those of their HIV-negative counterparts residing in the same regions [4], allowing HIV infection to be regarded as a manageable chronic condition.

Accordingly, emergency department (ED) utilization by PWH is projected to rise concomitant with the aging of PWH. Indeed, comparative analyses indicate higher rates of ED use among PWH relative to HIV-negative populations [5]. An analysis of the US National Hospital Ambulatory Medical Survey demonstrated that the rates of ED visits among PWH continue to exceed those among non-infected people (633 vs. 438 visits per 1000 people) [6]. Moreover, HIV-related ED visits reflected higher resource utilization, including longer ED stays and higher hospital admission rates [7, 8].

Therefore, this study aimed to elucidate patterns of ED utilization by PWH at a university hospital in South Korea over a 10-year period using visit-level data. Furthermore, characteristics of direct hospital admissions from the ED were compared to discharged visits to elucidate associated admission factors. Additionally, data were analyzed to identify key indicators predicting poor prognosis. We aspired to equip emergency physicians with analytic insights from 10 years of institutional data for PWH presenting to the ED.

2. Material and methods

2.1 Study design

This single-center retrospective study investigated characteristics of HIV-positive adult patients presenting to the ED of an 895-bed university hospital between 01 January 2013 and 31 December 2022. Per annual ED census data, the hospital serves approximately 60,000 patients annually. Referrals are unnecessary for ED access in South Korea, with governmental subsidization of all medical expenses for HIV care upon registration at a public health center.

Visits were categorized into direct hospital admissions from the ED or discharges to home to evaluate admission-associated factors. Additionally, visits in the poor prognosis group were compared with the remainder to evaluate prognostic indicators. The poor prognosis group was defined as admitted visits with intensive care unit (ICU) placement, visits with in-hospital mortality, or both.

2.2 Study population

Records were retrospectively reviewed for patients aged ≥18 years diagnosed with HIV infection who visited the ED between January 2013 and December 2022. Exclusion criteria encompassed the unawareness of positive HIV serostatus upon initial ED presentation, death prior to arrival, discharge against medical advice, and minor procedural indications including lumbar punctures, intravenous albumin-paired paracenteses, antibiotic injections, or wound dressing.

2.3 Data collection and definitions

The following variables were extracted from medical records of HIV-positive ED patients: age, sex, Korean Triage and Acuity Scale (KTAS) level, ambulance transport, reason for visit, comorbidities, duration of HIV diagnosis and highly active ART (HAART), vital sign measurements, laboratory results, supplemental oxygen necessity in the ED, ancillary department consults, ED length of stay, and cumulative ED presentations over the 10-year study period. For admitted cases, the assigned location (general ward versus ICU), hospital length of stay, and in-hospital mortality were additionally documented.

Overlapping reasons for visit were grouped with the five most prevalent indications utilized for statistical evaluations, as follows: (1) abdominal pain and/or nausea/vomiting; (2) fever; (3) injury or poisoning; (4) general weakness or poor oral intake; and (5) skin rashes. HIV-associated variables including the most recent cluster determinant 4 (CD4) count, and HIV viral load were also collected via chart review. The number of years since HIV diagnosis was counted as one from the next year of HIV diagnosis.

All parameters were recorded per visit, incorporating multiple presentations by given patients over the 10-year timeframe, with total ED visits per patient also recorded. Select variables such as age, KTAS level, CD4 count, and viral load were further grouped for analytical purposes.

2.4 Statistical analyses

Data with a normal distribution were expressed as mean ± standard deviation, whereas data with a skewed distribution were expressed as median and interquartile range (IQR). First, patients were divided into the discharge and admission groups, and the characteristics of each group were compared. Given that patients could contribute to multiple visits at different time points in our study, we used the generalized estimating equation (GEE) method with an exchangeable correlation structure to produce regression estimates when analyzing repeated measures [9]. Statistical significance was set at p < 0.05. Second, the poor prognosis group was compared to the remainder, and variables with a p value of < 0.10 in the simple model were candidates for the multiple models to investigate independent prognostic factors. The p value was relaxed to p < 0.10 to prevent exclusion of potentially meaningful clinical factors. All the statistical analyses were performed using SAS (version 9.4, SAS Institute, Cary, NC, USA).

3. Results

3.1 Overall characteristics

During the study period, a total of 369 ED visits corresponding to 183 discrete HIV-positive patients were included in the analysis. Fig. 1 depicts temporal trends in annual ED visit frequency and admission rates among HIV-positive patients over the 10-year period. An average of 8.9 per 10,000 ED visits are made by PWH annually, with an overall admission rate of 49.8%.

Annual changes of visit numbers of HIV-positive patient and 
their admission rates via ED. HIV, human immunodeficiency virus; ED, 
emergency department.

Fig. 1.Annual changes of visit numbers of HIV-positive patient and their admission rates via ED. HIV, human immunodeficiency virus; ED, emergency department.

Baseline features of the study population’s ED presentations are summarized in Tables 1 and 2. Most visits (88%) occurred among male patients, with predominant reasons for presentation encompassing abdominal pain and/or nausea/vomiting (17%), fever (13%), injury or poisoning (11%), general weakness or poor oral intake (11%), and skin rashes (5%). Suicide attempts were made in 10 visits (2.7%). Psychiatric and malignant comorbid conditions affected 33% and 21% of visits, respectively. The median interval from initial HIV diagnosis was 8 years; over 90% of cases demonstrated current HAART receipt and CD4 counts ≥200 cells/mL within one year of the documented visits.

Table 1.Baseline characteristics of visits by HIV-positive patients presenting to the emergency department (ED) from January 2013 to December 2022.
CharacteristicsNumber (%)Median (IQR)
Demographics
Age, years
18–29 years46 (12)48 (36–58)
30–64 years262 (71)
≥65 years61 (17)
Male324 (88)
Arrived by ambulance99 (27)
KTAS
Level 1 (Resuscitation)6 (2)
Level 2 (Emergent)29 (8)
Level 3 (Urgent)206 (56)
Level 4 (Less urgent)105 (28)
Level 5 (Non-urgent)23 (6)
Reasons for visit
Abdominal pain, Nausea/vomiting61 (17)
Fever47 (13)
Injury, Poisoning41 (11)
General weakness, Poor oral intake40 (11)
Skin rash20 (5)
Miscellaneous160 (43)
Comorbid conditions
Diabetes mellitus77 (21)
Hypertension65 (18)
Cardiovascular disease31 (8)
Chronic renal failure25 (7)
Rheumatologic disease21 (6)
Malignancy78 (21)
Neurodegenerative disease36 (10)
Psychiatric disease85 (33)
HIV clinical variables
Years since HIV diagnosis8 (3–12)
On HAART342 (93)
HIV laboratory variablesMissing data, 27
Viral load (copies/mL)
<200283 (83)
200–10540 (12)
≥10517 (5)
CD4 count (copies/mL)
<20061 (18)
200–499126 (37)
≥500153 (45)
IQR, Interquartile range; KTAS, Korean Triage and Acuity Scale; HIV, Human immunodeficiency virus; HAART, Highly active antiretroviral therapy; CD4, Cluster determinants 4.
Table 2.Clinical characteristics and outcome of 369 ED visits by HIV-positive patients over the ten years.
CharacteristicsNumber (%)Median (IQR)
Vital signs on presentation
SBP, mmHg130 (117–149)
DBP, mmHg80 (70–90)
PR, beats/min88 (76–105)
RR, breaths/min18 (18–18)
Body temperature, °C36.7 (36.3–37.2)
Saturation, %98 (96–98)
Laboratory findings
Complete blood cell counts
Leukocyte count, ×109 cells/mL7780 (5695–10,582)
Hemoglobin, g/dL13.9 (11.9–14.9)
Platelet, ×103/µL215 (170–264)
Other laboratory findings
Glucose, mg/dL114 (99–149)
Blood urea nitrogen, mg/dL14.5 (10.7–20.0)
Creatinine, mg/dL0.93 (0.79–1.14)
CRP, mg/dL0.7 (0.1–4.9)
HCO3, mmol/L22.7 (20.0–24.7)
Lactic acid, mmol/L1.7 (1.1–2.5)
Courses in ED
Use of oxygen at ED47 (13)
Consultation with other departments250 (68)
Length of ED stay (min)207 (133–314)
Number of ED visits during the study period3 (1–5)
Admission characteristics
Admitted186 (50)
ICU admission directly from ED26 (7)
Hospital days (n = 186)9 (5–18)
In-hospital mortality18 (5)
IQR, Interquartile range; SBP, Systolic blood pressure; DBP, Diastolic blood pressure; PR, Pulse rate; RR, Respiratory rate; ED, Emergency department; ICU, Intensive care unit.

As shown in Table 2, half of ED presentations culminated in hospital admission with a median ensuing stay of 9 days. ICU-level care was necessitated for 26 visits (7%) directly from the ED, while 18 registered in-hospital deaths amounted to a 5% visit-based mortality rate. Over the 10-year study period, the median number of ED visits per patient was 3 (range, 1–19 visits).

3.2 Comparison between the admission and discharge group

Parameters exhibiting statistically significant differences between the admission and discharge cohorts appear in Table 3. Regarding comorbidities, chronic renal failure (CRF) increased the odds of admission by 17.7 times (p = 0.001). Additionally, patients in the admission group were more likely to present to the ED with fever, general weakness, or poor oral intake, whereas skin rashes were more common in the discharge group. Specifically, presenting with fever had a threefold increase in the odds of admission (p = 0.001), while presenting with skin rash had a twofold increase in the odds of discharge (p = 0.001) compared with other reasons for visit, except for the five main complaints. In addition, the use of oxygen and consultation with other departments increased the odds of admission by 4.3 and 4.7 times, respectively (p = 0.0004 and p < 0.0001).

Table 3.Comparison of the admission and discharge groups among visits of patients with HIV presenting to the ED.
CharacteristicsDischarge group (n = 183)Admission group (n = 186)ßSEExp(ß) (95% CI)p value
Demographics
Age, no (%)
18–29 years35 (19)11 (6)−0.8000.3440.449 (0.228–0.882)0.020
30–64 years120 (66)140 (75)reference
Male152 (83)172 (92)0.8400.4252.318 (91.007–5.333)0.047
Arrived by ambulance33 (18)66 (35)0.7050.2572.025 (1.222–3.357)0.006
KTAS group
Level 1, 2 (Resuscitation, Emergent)9 (26)26 (74)1.7650.4025.844 (2.655–12.864)
Level 3 (Urgent)74 (40)132 (71)1.4360.2644.203 (2.508–7.044)<0.0001
Level 4, 5 (Less urgent, Non urgent)100 (55)28 (15)reference<0.0001
Reason for visit group
Abdominal pain, Nausea/vomiting27 (15)34 (18)0.5900.2831.805 (1.036–3.144)0.037
Fever12 (7)35 (19)1.1040.3443.017 (1.537–5.923)0.001
General weakness, Poor oral intake8 (4)32(17)1.0620.3262.893 (1.525–5.489)0.001
Skin rash19 (10)2 (1)−0.7190.3530.487 (0.243–0.973)0.041
Others88 (48)71 (38)reference
Comorbid conditions
Hypertension21 (11)44 (24)0.6700.3141.954 (1.054–3.622)0.033
Chronic renal failure1 (1)24 (13)2.9320.90717.781 (3.173–111.141)0.001
Vital signs on presentation
DBP, mmHg80 (76–93)78 (68–89)−0.0180.0060.981 (0.968–0.994)0.006
RR, breaths/min18 (18–18)18 (18–20)0.1760.0481.191 (1.084–1.312)0.0003
Saturation, %98 (97–99)97 (95–98)−0.2900.0710.748 (0.650–0.860)<0.0001
Laboratory findings
Leukocyte count, ×109 cells/mL7390 (5940–9620)8015 (5420–11,430)0.00010.0001.000 (1.000–1.000)0.042
Blood urea nitrogen, mg/dL12.5 (9.75–16.15)16.1 (11.6–23.6)0.0790.0201.083 (1.041–1.126)<0.0001
Creatinine, mg/dL0.93 ± 0.230.96 (0.79–1.22)0.9370.3122.533 (1.384–4.709)0.002
CRP, mg/dL0.26 (0.07–1.03)3.11 (0.26–9.96)0.2700.0431.310 (1.203–1.427)<0.0001
Courses in ED
Use of oxygen at ED7 (4)40 (22)1.4710.4174.356 (1.920–9.881)0.0004
Consultation to other departments88 (49)162 (88)1.5520.2334.720 (2.984–7.466)<0.0001
SE, Standard error; CI, Confidence interval; KTAS, Korean triage and acuity scale; DBP, Diastolic blood pressure; RR, Respiratory rate; CRP, C-reactive protein; ED, Emergency department.

3.3 Independent prognostic factors

We compared the poor prognosis group (n = 37), who were admitted directly to the ICU and/or died during the hospital course, with the remainder of the visits (n = 332). The poor prognosis group consisted of 18 patients died during hospitalization (11 died in the ED and 7 in the ICU) and 19 visits who survived after ICU care. In a simple model analysis, the following variables were statistically significant (p < 0.0001) in the poor prognosis group; arrived by ambulance (odds ratio (OR) = 5.78, 95% confidence interval (CI) = 2.92–11.42), KTAS level 1, 2 over KTAS level 4, 5 (OR = 8.255, 95% CI = 4.29–428.79), and use of oxygen at ED (OR = 9.558, 95% CI = 4.49–20.34). Multiple model analysis was performed with significant variables (with a p value of < 0.10 in the simple model) only from comorbid conditions and laboratory findings (Table 4). The odds of poor prognosis were increased 1.9 and 1.6 times for a 10-unit increase in BUN and a 1-unit increase in lactic acid levels, respectively (p = 0.0002 and p < 0.0001).

Table 4.Poor prognostic factors were identified by comparing the poor prognostic group (those who were admitted directly to the intensive care unit and died during the hospital course) with the rest of the ED visits of HIV-positive patients.
CharacteristicsSimple modelMultiple model
Exp(ß) (95% CI)p valueExp(ß) (95% CI)p value
Comorbid conditions
Diabetes2.679 (1.168–6.142)0.019
Hypertension3.986 (1.814–8.758)0.0006
Chronic renal failure2.329 (0.761–7.132)0.138
Laboratory findings
Glucose, mg/dL1.003 (1.000–1.005)0.020
Blood urea nitrogen, mg/dL1.069 (1.032–1.106)0.0002
Creatinine, mg/dL1.187 (1.072–1.315)0.001
CRP, mg/dL1.059 (1.004–1.121)0.048
HCO3, mmol/L0.885 (0.814–0.961)0.004
Lactic acid, mmol/L1.613 (1.289–2.018)<0.0001
CI, Confidence interval; CRP, C-reactive protein.

4. Discussion

This study expanded beyond simply describing ED utilization profiles of PWH which distinguishes our analysis from preceding studies. We elucidated multiple variables associated with heightened admission odds from the ED including underlying chronic renal failure, presenting with fever or general weakness, supplemental oxygen administration, and ancillary department involvement. Furthermore, we uniquely sought to delineate prognostic indicators for this population in the emergency care setting. As expected, ambulance arrival, urgent triage acuity, and oxygen needs were associated with poor prognosis. Notably, incremental elevations in BUN or lactic acid each were independent factors for poor prognosis.

Studies worldwide have investigated ED utilization patterns among HIV-positive adults with descriptions of demographic and HIV disease-specific variables [5, 6, 7, 8, 9]. For example, a 2019 Belgian study retrospectively reviewed 1026 patients, finding trauma-related discharge diagnoses most prevalent overall at 30% [10]. Some analyses have explored predictors of ED use frequency in HIV-positive cohorts, and Venkat et al. [11] identified levels of income and a viral load were significantly related to ED utilization in the United States. In a cross-sectional survey by the HIV Research Network, ED use was also associated with Medicaid insurance, high levels of pain, current or former illicit drug use, social alcohol use, and female gender [12]. However, per our literature review no existing investigations have elucidated prognostic outcomes particular to HIV-infected ED patients.

Our results for HIV disease control markers aligned with previously published South Korean national data. Cho et al. [13] evaluated the proportion of PWH receiving ART among all PWH using the Korean National Health Insurance between 2006 and 2015. The proportion of PWH who received ART increased from 55.4% in 2006 to 87.6%. Correspondingly, Choi et al. [14] reported a viral load suppression rate exceeding 90% among a 2019 national HIV cohort. The likewise high levels of virologic control observed herein likely explain the absence of significant relationships between HIV-related variables (such as years since HIV diagnosis, HARRT-taking, viral loads, and CD4 counts) and admission likelihood or prognosis. Restricting our analysis only to patients aware of their positive HIV serostatus at the ED visit may have further diluted any potential associations attributable to disease severity.

One of the primary limitations of our study was that it was conducted at a single healthcare institution, which may not fully represent the broader population of HIV-infected individuals seeking emergency care. Variations in patient demographics, healthcare practices, and resource availability across institutions could have influenced the findings. Therefore, caution should be exercised when generalizing these results to the entire population.

Additionally, we conducted our analysis based on a sample size of 369 visits, which could be considered relatively small. Particularly, only 37 visits were included in the poor prognosis group, which may have affected the reliability and precision of the results. Further multicenter studies on ED utilization by PWH should be conducted with a larger sample size to ensure a more comprehensive understanding and reliable analytical results.

5. Conclusions

In summary, this study identified underlying chronic renal failure, presenting with fever or general weakness/poor oral intake, supplemental oxygen necessity, and ancillary department consultation as factors related to hospital admission from the ED in HIV patients. Ambulance transport, high KTAS level and use of oxygen in the ED presaged poorer prognosis, along with elevations in serum BUN or lactic acid. We hope these data will assist emergency physicians in providing timely informed care to HIV-infected individuals visiting the ED, ultimately leading to improved patient outcomes.

Availability of data and materials

The data presented in this study are available on reasonable request from the corresponding author.

Author contributions

JHK and SBH—designed the research study. YJL—performed the research. CHL, YJS and SL—analyzed the data. AD and SL—wrote the manuscript. All authors read and approved the final manuscript.

Ethics approval and consent to participate

This study was approved by the Institutional Review Board of Inha University Hospital, Incheon, South Korea (IRB no. 2023-04-031), and was conducted in accordance with the Declaration of Helsinki. The need for informed consent was waived due to the retrospective nature of this study.

Acknowledgment

Not applicable.

Funding

This study was supported by Inha University Research Grant: 70502-01.

Conflict of interest

The authors declare no conflict of interest.

References

UNAIDS. 2023 UNAIDS global AIDS update. 2023. Available at: https://www.unaids.org/en/resources/documents/2023/global-aids-update-2023 (Accessed: 14 February 2024).

[Google Scholar]

Korea Centers for Disease Control and Prevention. Annual report on the notified HIV/AIDS in Korea 2022. 2022. Available at: https://dportal.kdca.go.kr/pot/bbs/BD_selectBbs.do?q_bbsSn=1010&q_bbsDocNo=20230630735881389&q_clsfNo=1 (Accessed: 14 February 2024).

[Google Scholar]

Gandhi RT, Bedimo R, Hoy JF, Landovitz RJ, Smith DM, Eaton EF, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults. JAMA. 2023; 329: 63–84.

[Google Scholar]

Trickey A, Sabin CA, Burkholder G, Crane H, d’Arminio Monforte A, Egger M, et al. Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies. The Lancet HIV. 2023; 10: e295–e307.

[Google Scholar]

Ng R, Kendall CE, Burchell AN, Bayoumi AM, Loutfy MR, Raboud J, et al. Emergency department use by people with HIV in Ontario: a population-based cohort study. CMAJ Open. 2016; 4: E240–E248.

[Google Scholar]

Mohareb AM, Rothman RE, Hsieh YH. Emergency department (ED) utilization by HIV-infected ED patients in the United States in 2009 and 2010—a national estimation. HIV Medicine. 2013; 14: 605–601.

[Google Scholar]

Abia A, Rothman RE, Mohareb AM, Lim GLH, Patel AV, Bigelow B, et al. Resource utilization across the continuum of HIV care: an emergency department-based cohort study. The American Journal of Emergency Medicine. 2021; 43: 164–169.

[Google Scholar]

Siddiqi KA, Liu Y, Ding DD, Olatosi BA. Estimating resource utilization for emergency department visits by patients’ HIV seropositivity in the United States, 2009 to 2018. The American Journal of Emergency Medicine. 2022; 53: 73–79.

[Google Scholar]

Hardin JW, Hilbe JM. Generalized estimating equations. 1st edn. Chapman & Hall/CRC: Boca Raton. 2002.

[Google Scholar]

Pirotte B, Frippiat F, Darcis G, Rassenfosse M, Fombellida K, Maes N, et al. Emergency department utilization by HIV-positive adults in a Belgian setting. The Medical Review of Liege. 2019; 74: 28–35. (In French)

[Google Scholar]

Venkat A, Shippert B, Hanneman D, Nesbit C, Piontkowsky DM, Bhat S, et al. Emergency department utilization by HIV-positive adults in the HAART era. International Journal of Emergency Medicine. 2008; 1: 287–296.

[Google Scholar]

Josephs JS, Fleishman JA, Korthuis PT, Moore RD, Gebo KA; HIV Research Network. Emergency department utilization among HIV-infected patients in a multisite multistate study. HIV Medicine. 2010; 11: 74–84.

[Google Scholar]

Cho Y, Chin B. Assessment of human immunodeficiency virus care continuum in Korea using the national health insurance system data. Infection & Chemotherapy. 2021; 53: 477–488.

[Google Scholar]

Choi JP. The HIV care cascade in Korea: status of UNAIDS 90-90-90 targets. Journal of Korean Medical Science. 2020; 35: e55.

[Google Scholar]